← Leaderboards
David E. Williams
Oregon State University
$14,401,927
Attributed
$14,401,927
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.1M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$31,806,405 · 12
By mechanism
P42$17,999,030 · 4
R01$8,018,015 · 3
T32$2,409,203 · 1
P30$2,127,828 · 1
P01$1,208,047 · 1
T35$30,282 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon State University
Same institution · by research overlap
- Abby D Benninghoff$556,089
- William M Baird$2,677,287
- George S Bailey$301,483
- Jerry D Hendricks$278,750
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelLaboratoriesAromatic Polycyclic HydrocarbonsToxic EffectProgramsGrantRisk AssessmentInnovationNew TechnologyGeneral PopulationSuperfund SiteExposure ToEnvironmentUniversitiesOregonMetabolismTechnologyCarcinogenesisDosePacific NorthwestBaseResponseEnvironmental HealthExhibits
Grant awards (72)
Benzo[a]pyrene Micro-dosing of Humans: A New Tool for Exposure, Risk Assessment and Prevention$460,228
R01 · FY2022 · ES · contact PI
Benzo[a]pyrene Micro-dosing of Humans: A New Tool for Exposure, Risk Assessment and Prevention$460,235
R01 · FY2021 · ES · contact PI
Benzo[a]pyrene Micro-dosing of Humans: A New Tool for Exposure, Risk Assessment and Prevention$503,436
R01 · FY2020 · ES · contact PI
Benzo[a]pyrene Micro-dosing of Humans: A New Tool for Exposure, Risk Assessment and Prevention$503,711
R01 · FY2019 · ES · contact PI
Core A: Administrative Core$397,097
P42 · FY2019 · ES · contact PI
Benzo[a]pyrene Micro-dosing of Humans: A New Tool for Exposure, Risk Assessment and Prevention$580,890
R01 · FY2018 · ES · contact PI
Project 1: PAHs in Humans at Environmental Levels Pharmacokinetics, Metabolism a$289,744
P42 · FY2017 · ES · contact PI
Core A: Administrative Core$74,012
P42 · FY2017 · ES · contact PI
Project 1: PAHs in Humans at Environmental Levels Pharmacokinetics, Metabolism a$283,829
P42 · FY2016 · ES · contact PI
Project 1: PAHs in Humans at Environmental Levels Pharmacokinetics, Metabolism a$88,347
P42 · FY2016 · ES · contact PI
Core A: Administrative Core$72,502
P42 · FY2016 · ES · contact PI
Project 1: PAHs in Humans at Environmental Levels Pharmacokinetics, Metabolism a$295,652
P42 · FY2015 · ES · contact PI
Core A: Administrative Core$75,522
P42 · FY2015 · ES · contact PI
Project 1: PAHs in Humans at Environmental Levels Pharmacokinetics, Metabolism a$291,895
P42 · FY2014 · ES · contact PI
Transplacental Chemoprevention of Lung Tumors and Lymphomas$260,425
P01 · FY2014 · CA · contact PI
Core A: Administrative Core$72,830
P42 · FY2014 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$10,800
P42 · FY2014 · ES · contact PI
Project 1: PAHs in Humans at Environmental Levels Pharmacokinetics, Metabolism a$983
P42 · FY2014 · ES · contact PI
Core A: Administrative Core$982
P42 · FY2014 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$3,117,308
P42 · FY2013 · ES · contact PI
Flavin-Containing Monooxygenase in Lung$331,109
R01 · FY2013 · HL · contact PI
Project 1: PAHs in Humans at Environmental Levels Pharmacokinetics, Metabolism a$295,652
P42 · FY2013 · ES · contact PI
Transplacental Chemoprevention of Lung Tumors and Lymphomas$216,948
P01 · FY2013 · CA · contact PI
Core A: Administrative Core$87,022
P42 · FY2013 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$10,800
P42 · FY2013 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$10,800
P42 · FY2013 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$2,888,367
P42 · FY2012 · ES · contact PI
Flavin-Containing Monooxygenase in Lung$347,804
R01 · FY2012 · HL · contact PI
Transplacental Chemoprevention of Lung Tumors and Lymphomas$216,317
P01 · FY2012 · CA · contact PI
Core A: Administrative Core$115,702
P42 · FY2012 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$10,800
P42 · FY2012 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$2,910,352
P42 · FY2011 · ES · contact PI
Flavin-Containing Monooxygenase in Lung$359,770
R01 · FY2011 · HL · contact PI
Transplacental Chemoprevention of Lung Tumors and Lymphomas$287,188
P01 · FY2011 · CA · contact PI
Core A: Administrative Core$115,178
P42 · FY2011 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$2,977,073
P42 · FY2010 · ES · contact PI
Flavin-Containing Monooxygenase in Lung$338,818
R01 · FY2010 · HL · contact PI
Transplacental Chemoprevention of Lung Tumors and Lymphomas$227,169
P01 · FY2010 · CA · contact PI
PAHs: New Technologies and Emerging Health Risks$49,050
P42 · FY2010 · ES · contact PI
Core A: Administrative Core$45,936
P42 · FY2010 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$20,000
P42 · FY2010 · ES · contact PI
The 5th Aquatic Animal Models for Human Disease Conference$14,000
R13 · FY2010 · RR · contact PI
PAHs: New Technologies and Emerging Health Risks$3,035,716
P42 · FY2009 · ES · contact PI
PAHs: New Technologies and Emerging Health Risks$235,584
P42 · FY2009 · ES · contact PI
Core A: Administrative Core$119,495
P42 · FY2009 · ES · contact PI
Ultra-Low Dose Carcinogen Testing with the Trout Model$108,720
R01 · FY2009 · ES · contact PI
Ultra-Low Dose Carcinogen Testing with the Trout Model$434,603
R01 · FY2008 · ES · contact PI
Flavin-containing Monooxygenase in Lung$282,472
R01 · FY2008 · HL · contact PI
Ultra-Low Dose Carcinogen Testing with the Trout Model$493,573
R01 · FY2007 · ES · contact PI
Flavin-containing Monooxygenase in Lung$282,732
R01 · FY2007 · HL · contact PI
Ultra-Low Dose Carcinogen Testing with the Trout Model$501,768
R01 · FY2006 · ES · contact PI
Marine and Freshwater Biomedical Sciences Center$422,645
P30 · FY2006 · ES · contact PI
Flavin-containing Monooxygenase in Lung$291,429
R01 · FY2006 · HL · contact PI
Ultra-Low Dose Carcinogen Testing with the Trout Model$429,453
R01 · FY2005 · ES
Marine and Freshwater Biomedical Sciences Center$422,683
P30 · FY2005 · ES
MODE OF ACTION OF ENVIRONMENTAL TOXICANTS$420,992
T32 · FY2005 · ES
Flavin-containing Monooxygenase in Lung$309,059
R01 · FY2005 · HL
MODE OF ACTION OF ENVIRONMENTAL TOXICANTS$435,643
T32 · FY2004 · ES
Marine and Freshwater Biomedical Sciences Center$424,500
P30 · FY2004 · ES
Flavin-Containing Monooxygenase in Lung$250,250
R01 · FY2004 · HL
MARINE &FRESHWATER BIOMEDICAL SCIENCES CENTER GRANT$429,000
P30 · FY2003 · ES
MODE OF ACTION OF ENVIRONMENTAL TOXICANTS$427,560
T32 · FY2003 · ES
Flavin-Containing Monooxygenase in Lung$250,250
R01 · FY2003 · HL
MODE OF ACTION OF ENVIRONMENTAL TOXICANTS$404,573
T32 · FY2002 · ES
MARINE &FRESHWATER BIOMEDICAL SCIENCES CENTER GRANT$357,500
P30 · FY2002 · ES
Flavin-Containing Monooxygenase in Lung$250,250
R01 · FY2002 · HL
MARINE &FRESHWATER BIOMEDICAL SCIENCES CENTER GRANT$71,500
P30 · FY2002 · ES
MODE OF ACTION OF ENVIRONMENTAL TOXICANTS$378,752
T32 · FY2001 · ES
Flavin-Containing Monooxygenase in Lung$247,455
R01 · FY2001 · HL
SHORT-TERM RESEARCH TRAINING FOR MINORITY STUDENTS$16,351
T35 · FY2001 · ES
MODE OF ACTION OF ENVIRONMENTAL TOXICANTS$341,683
T32 · FY2000 · ES
SHORT-TERM RESEARCH TRAINING FOR MINORITY STUDENTS$13,931
T35 · FY2000 · ES